drugset / Trial / NCT07357220
A Study of AK112 in Combination With VG2025 in Colorectal Cancer With Liver Metastases
RandomizedSequentialOpen-labelTreatment
Summary
An open-label, multicenter, phase Ib/II study of AK112 in combination with VG2025 for advanced colorectal cancer with liver metastases.
Timeline
- Start
- 2026-03-02
- Primary completion
- 2027-02-28
- Completion
- 2028-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ivonescimab | Monoclonal antibody | 20 mg/kg | Intravenous |
| Subject | VG2025 | Unknown | — | Other |